Thompson, Ronald G. Jr.
Bollinger, Mary
Mancino, Michael J.
Hasin, Deborah
Han, Xiaotong
Bush, Keith A.
Kilts, Clint D.
James, G. Andrew http://orcid.org/0000-0002-2940-2746
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA048022)
National Institute of General Medical Sciences (R01DA048022)
Article History
Received: 24 January 2023
Accepted: 1 March 2023
First Online: 4 April 2023
Declarations
:
: This study protocol has been approved by the UAMS Institutional Review Board (protocol #274084). Per the protocol, the study investigators and staff will obtain written informed consent from all study participants.
: Not applicable: no identifying images or other personal or clinical details of participants are presented here nor will be presented in reports of the trial results. Informed consent materials are attached as supplementary materials. Relevant protections from supplementary materials against the loss of confidentiality are re-iterated in the “Protection against loss of confidentiality” section.
: Drs. James, Thompson, and Bollinger will apply for patent and/or trademark protection for the OptiMAT smartphone app. The authors declare no other competing financial or non-financial interests.